A Positive Feedback DNA-PK/MYT1L-CXCR1-ERK1/2 Proliferative Signaling Loop in Glioblastoma

Area of Science:

• Molecular Biology
• Oncology
• Cell Signaling

Background:

• Glioblastoma is the most aggressive primary brain tumor in adults.
• Myelin transcription factor 1-like (MYT1L) and DNA-dependent protein kinase (DNA-PK) interplay in p21 transcription.
• The role of this interplay in glioblastoma pathogenesis is largely unknown.

Purpose of the Study:

• To investigate the functional interplay between DNA-PK and MYT1L in glioblastoma.
• To elucidate the role of this interaction in regulating CXC chemokine receptor 1 (CXCR1) transcription.
• To identify a potential therapeutic target loop in glioblastoma.

Main Methods:

• Utilized cell lines with normal or deficient DNA-PK (HEK293, M059K, M059J).
• Employed conventional techniques, bioinformatics analysis, and luciferase assays.
• Investigated MYT1L's effect on cell proliferation, apoptosis, cell cycle, and CXCR1 transcription.

Main Results:

• DNA-PK-dependent MYT1L activation controls CXCR1 transcription in glioblastoma.
• MYT1L acts as an oncogene in DNA-PK-normal cells (proliferation, anti-apoptosis) but a tumor suppressor in DNA-PK-deficient cells (G1 arrest).
• A positive feedback loop (DNA-PK/MYT1L-CXCR1-ERK1/2) was identified, promoting glioblastoma cell proliferation.

Conclusions:

• The DNA-PK/MYT1L-CXCR1-ERK1/2 signaling axis is crucial for glioblastoma proliferation.
• MYT1L's function is context-dependent on DNA-PK status.
• This proliferation loop represents a promising pharmacological target for glioblastoma therapy.